News

MedTech Dive2d
Tandem, Abbott team on insulin delivery with glucose-ketone sensor
Tandem will integrate its insulin delivery systems with a new dual glucose-ketone sensor being developed by Abbott.
Not Ozempic, in India THIS weigh-loss and diabetes drug from Eli Lilly sees sales jump 60% — what is it?
Eli Lilly's weight-loss and diabetes drug Mounjaro, has seen sales in India jump 60 per cent between April and May. The ...
The ‘golden dose’ of Mounjaro that experts warn could be deadly – as slimmers rave about it saving money
A GROWING number of slimmers are trying to squeeze extra jabs out of empty Mounjaro pens in a risky bid to cut costs. The ...
Biocon, Wockhardt, Eris to double insulin output, as global drugmakers scale back to focus on GLP-1, new generation insulins
Human insulin presents Indian companies an opportunity estimated at Rs 450 crore per annum in India and $157 million/annum in emerging markets.